≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Migraine, unspecified, drug-induced

EFO Endpoint Browser PheWeb

MIGRAINE_UNSPE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs — ANY
  • Hospital discharge: ICD-10 — G43.9#

1 out of 7 registries used, show all original rules.

280

4. Check minimum number of events

None

280

5. Include endpoints

None

280

6. Filter based on genotype QC (FinnGen only)

250

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 250 201 49
Unadjusted period prevalence (%) 0.06 0.07 0.02
Median age at first event (years) 36.65 37.29 34.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
260
Matched controls
2600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G43.9
ICD-10 Finland
Migraine, unspecified
+∞
275.7
260
119
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
12.9
99.9
157
275
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
13.5
82.1
94
105
N02CX04, ,
ATC
23.7
55.9
42
21
N02CC04
ATC
rizatriptan; oral
9.6
52.0
72
100
N02CC03
ATC
zolmitriptan; nasal, oral
8.9
49.0
72
107
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
8.2
47.3
76
125
N02CC02
ATC
naratriptan; oral
15.7
41.7
38
28
G43.3
ICD-10 Finland
Complicated migraine
18.5
40.8
34
21
N02CC06
ATC
eletriptan; oral
11.0
40.5
47
51
N03AX11
ATC
topiramate; oral
12.1
39.7
43
42
N06CA01
ATC
amitriptyline and psycholeptics; systemic
6.2
34.8
73
155
N02CC05
ATC
almotriptan; oral
8.2
30.7
45
65
M01AG02
ATC
tolfenamic acid; oral, rectal
4.7
30.4
100
308
R51.80
ICD-10 Finland
Headache
4.1
25.6
99
338
N02CC07
ATC
frovatriptan; oral
6.3
23.8
44
81
A03FA01
ATC
metoclopramide; systemic, rectal
3.8
23.7
110
423
N89
ICPC
Migraine
7.3
23.3
37
58
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
21.5
23.3
34
18
N03AG01
ATC
valproic acid; systemic, rectal
5.9
22.6
45
89
N06AA09
ATC
amitriptyline; systemic
4.6
21.0
59
157
G43
ICD-10 Finland
Migraine
5.6
20.0
42
87
C07AA05
ATC
propranolol; systemic
3.3
18.4
103
434
G44.2
ICD-10 Finland
Tension-type headache
3.6
18.1
78
279
M01AE03
ATC
ketoprofen; systemic, rectal
3.1
18.1
137
686
3007
Kela drug reimbursment
Erenumab and fremanezumab
21.1
17.2
25
13
G43.8
ICD-10 Finland
Other migraine
14.1
16.6
28
22
C07AB02
ATC
metoprolol; systemic
3.5
16.4
69
242
C08DA01
ATC
verapamil; systemic
6.2
15.9
29
52
N05BA01
ATC
diazepam; systemic, rectal
3.4
14.3
61
214
C07AB07
ATC
bisoprolol; oral
2.6
13.2
141
807
N02AX02
ATC
tramadol; systemic, rectal
2.6
12.9
142
822
N02CD01
ATC
erenumab; parenteral
25.8
12.6
17
7
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
12.4
40
116
N05AB04
ATC
prochlorperazine; systemic, rectal
11.9
12.3
22
20
C09CA06
ATC
candesartan; oral
2.7
12.1
92
443
AA1AD
NOMESCO Finland
CT of head and brain
2.6
11.8
92
447
R07.4
ICD-10 Finland
Chest pain, unspecified
2.6
11.7
98
492
N03AX12
ATC
[U] gabapentin; oral
2.9
11.6
69
291
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
11.0
129
752
R518, ,
ICD-10 Finland
45.4
11.0
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
10.6
93
475
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.1
10.5
49
180
A02BC01
ATC
omeprazole; systemic
2.5
10.5
89
447
A02BA02
ATC
ranitidine; systemic
2.7
10.5
67
293
J01MA02
ATC
ciprofloxacin; systemic
2.4
10.4
115
651
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
10.3
71
322
H02AB07
ATC
prednisone; oral
3.0
10.2
50
189
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
41.8
10.0
12
*
N02CD03
ATC
fremanezumab; systemic
14.1
9.8
16
12
M03BC51
ATC
orphenadrine, combinations; systemic
2.3
9.7
104
577
N06AX16
ATC
venlafaxine; oral
2.6
9.7
67
304
N06AX21
ATC
duloxetine; oral
2.8
9.6
56
232
N03AX16
ATC
[U] pregabalin
2.4
9.5
83
419
M01AB01
ATC
indometacin; systemic, rectal
4.6
9.3
23
54
A02BC02
ATC
pantoprazole; systemic
2.5
9.3
201
1487
H02AB06
ATC
prednisolone; systemic
2.2
9.1
143
921
N06AX11
ATC
mirtazapine; oral
2.2
9.1
119
713
H02AB04
ATC
methylprednisolone; systemic
2.7
8.9
53
222
M01AE02
ATC
naproxen; oral, rectal
2.3
8.4
179
1286
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
8.4
55
241
R11
ICD-10 Finland
Nausea and vomiting
3.2
8.4
36
125
R51
ICD-10 Finland
Headache
3.6
8.4
29
88
G43.2
ICD-10 Finland
Status migrainosus
34.5
8.1
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
8.0
113
689
N06AB04
ATC
citalopram; systemic
2.3
7.9
76
396
N02CA01
ATC
dihydroergotamine; nasal, systemic
46.4
7.8
9
*
R20.2
ICD-10 Finland
Paraesthesia of skin
3.1
7.7
34
120
ZXE00
NOMESCO Finland
One hour or less
2.1
7.7
119
748
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.7
7.6
25
73
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
7.1
138
936
N05CD07
ATC
temazepam; oral
2.9
6.9
35
134
J02AC01
ATC
fluconazole; systemic
2.0
6.8
141
971
N03AX09
ATC
lamotrigine; oral
3.3
6.8
26
84
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
6.8
66
344
M03BX02
ATC
tizanidine; oral
2.2
6.7
195
1512
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
6.7
47
212
G44.0
ICD-10 Finland
Cluster headache syndrome
9.1
6.6
13
15
A02BC05
ATC
esomeprazole; systemic
2.0
6.6
124
824
H60.9
ICD-10 Finland
Otitis externa, unspecified
3.0
6.6
30
108
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.3
6.5
54
263
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
6.4
70
381
M79.6
ICD-10 Finland
Pain in limb
1.9
6.3
139
971
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
6.3
46
212
N02AC04
ATC
dextropropoxyphene; oral
6.0
6.3
16
28
N01
ICPC
Headache
2.5
6.2
44
199
J01DA01
ATC
[U] cefalexin
2.0
6.2
181
1385
M03AX01
ATC
botulinum toxin; parenteral
8.9
6.1
12
14
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.1
6.1
26
90
Z2221
NOMESCO Finland
Medical doctor
2.0
6.1
85
507
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
6.0
81
476

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
84
417
2.50
10.08
3.9
3.5
32.07
143.81
ng/l
1.67
65
289
63
328
2.22
6.48
1.4
1.2
—
—
—
0
0
141
988
1.93
6.33
5.8
4.5
36.77
36.56
g/l
0.20
136
941
92
569
1.95
5.90
2.5
2.1
2.84
2.73
mg/l
0.17
74
487
48
234
2.29
5.73
2.8
2.3
42.31
28.87
u/l
0.88
42
198
172
1314
1.91
5.67
5.0
5.1
6.19
6.45
mmol/l
1.28
165
1231
39
176
2.43
5.53
1.3
1.3
—
—
—
0
0
88
552
1.90
5.32
1.4
1.3
30.57
24.38
iu/ml
0.19
25
179
88
562
1.86
4.98
2.0
1.7
1.31
1.01
mg/l
0.31
72
442
187
1502
1.87
4.88
5.9
4.5
1450.80
173.64
e6/l
—
5
25
66
386
1.95
4.87
1.4
1.4
366.15
523.75
titre
0.69
13
96
105
716
1.78
4.76
4.2
4.0
7.40
7.40
ph
0.03
77
492
97
655
1.77
4.49
1.3
1.3
0.66
1.24
u/ml
1.42
21
190
74
463
1.84
4.40
2.2
2.5
2.43
2.44
mmol/l
0.49
60
423
78
497
1.81
4.37
3.2
2.6
4.94
7.60
e6/l
0.82
70
462
51
288
1.96
4.13
3.3
2.5
4.60
6.04
umol/l
1.42
45
252
82
541
1.75
4.05
4.4
4.1
—
—
—
0
0
155
1214
1.69
4.04
3.4
3.1
86.28
94.82
ug/l
0.41
145
1144
78
510
1.76
3.96
1.4
1.3
1.20
12.29
u/ml
3.78
24
202
86
582
1.71
3.85
1.4
1.4
2.14
2.44
g/l
0.89
45
351
99
698
1.68
3.80
2.1
2.1
118.28
147.28
u/l
0.70
94
665
53
315
1.86
3.67
1.7
1.6
1125.21
1227.72
nmol/l
0.41
42
236
209
1799
1.82
3.65
8.5
7.9
73.49
76.90
u/l
0.81
201
1706
65
413
1.77
3.61
2.1
2.6
540.65
514.50
mosm/kgh2o
0.36
55
362
156
1245
1.63
3.60
6.6
6.2
1.94
2.00
e9/l
0.20
140
1103
111
818
1.62
3.53
2.5
3.3
2.35
2.36
mmol/l
0.89
101
756
131
1006
1.61
3.51
6.5
6.6
1.22
1.22
mmol/l
0.58
124
936
90
630
1.66
3.50
3.6
3.0
0.19
0.40
e6/l
1.35
71
438
81
553
1.68
3.46
4.3
3.7
1.02
1.02
kg/l
0.21
56
348
55
337
1.80
3.44
2.3
2.3
2.42
2.40
g/l
0.07
47
315
105
769
1.61
3.39
6.4
5.7
—
—
—
0
0
124
957
1.57
3.15
13.2
9.8
1.21
1.13
inr
0.88
104
772
100
735
1.59
3.13
4.4
3.2
27.37
34.37
e6/l
0.19
80
548
65
430
1.68
3.10
1.6
1.7
374.63
45380896.34
pmol/l
0.72
52
368
140
1115
1.55
3.06
6.9
7.1
1.22
1.22
mmol/l
0.43
120
959
136
1077
1.55
3.05
10.8
10.5
0.00
0.00
e9/l
1.16
106
871
249
2317
2.76
2.96
19.9
13.7
19.52
21.42
mg/l
0.44
216
1843
113
865
1.54
2.91
5.2
3.9
81.26
67.88
e6/l
0.11
86
573
26
133
2.06
2.77
1.2
1.2
—
—
—
0
0
10
29
3.54
2.72
2.1
1.8
—
—
—
0
0
10
29
3.54
2.72
2.1
1.8
—
—
—
0
0
10
29
3.54
2.72
2.1
1.8
—
—
—
0
0
10
29
3.54
2.72
2.1
1.8
—
—
—
0
0
125
990
1.51
2.69
2.3
2.0
96.45
99.53
pmol/l
0.34
68
484
140
1136
1.50
2.68
7.1
6.2
29.58
28.67
%
0.47
132
1084
15
61
2.55
2.67
1.5
2.1
—
—
—
0
0
148
1216
1.50
2.66
6.8
6.2
0.53
0.55
e9/l
0.52
126
1051
154
1277
1.51
2.63
6.8
6.4
0.19
0.18
e9/l
0.28
141
1118
52
341
1.66
2.54
3.3
2.9
2.35
3.35
e6/l
0.44
26
135
137
1119
1.47
2.46
7.1
6.1
57.33
56.92
%
0.16
130
1071
37
224
1.76
2.41
1.1
1.2
—
—
—
0
0
27
148
1.92
2.39
1.1
1.1
—
—
—
0
0
147
1222
1.47
2.39
6.8
6.2
0.04
0.04
e9/l
0.31
125
1053
48
315
1.64
2.34
2.4
2.4
20.51
22.79
%
0.72
42
295
161
1369
1.46
2.28
8.5
10.2
4.20
3.91
e9/l
0.85
139
1202
134
1101
1.45
2.27
2.6
2.5
77.23
78.04
nmol/l
0.11
124
1013
20
102
2.04
2.17
1.5
1.5
—
—
—
0
0
20
102
2.04
2.17
1.5
1.5
—
—
—
0
0
13
55
2.44
2.16
3.7
2.6
1.21
1.60
index
—
5
30
103
812
1.44
2.15
3.9
3.3
17.93
105.64
ng/l
0.58
65
509
94
729
1.45
2.14
5.1
6.5
—
—
—
0
0
20
103
2.02
2.12
1.5
1.5
—
—
—
0
0
19
96
2.06
2.11
1.5
1.5
—
—
—
0
0
40
258
1.65
2.08
2.0
1.5
—
—
—
0
0
211
1914
1.54
2.00
5.1
4.8
14.18
14.63
pmol/l
2.14
200
1789
150
1282
1.40
1.92
4.5
3.6
0.00
6.15
estimate
0.50
29
264
151
1293
1.40
1.91
4.5
3.7
0.00
0.01
estimate
0.50
28
246
90
707
1.42
1.87
3.1
2.7
—
0.20
—
0
10
21
117
1.86
1.80
2.8
2.3
5.45
5.32
iu/ml
—
8
24
75
575
1.43
1.78
1.8
2.7
300.08
321.46
umol/l
1.10
60
521
86
676
1.41
1.77
3.9
2.7
—
—
—
0
0
131
1105
1.37
1.76
7.3
6.2
0.67
0.73
%
0.64
123
1030
9
36
2.55
1.75
1.1
1.1
—
—
—
0
0
16
82
2.01
1.73
1.5
1.5
—
—
—
0
0
7
24
2.97
1.73
1.9
1.1
—
—
—
0
0
19
104
1.89
1.72
1.5
1.5
—
—
—
0
0
131
1109
1.37
1.71
7.4
6.2
8.16
8.63
%
1.56
123
1047
234
2196
1.66
1.66
5.8
5.8
37.54
38.50
mmol/mol
1.03
220
2085
130
1107
1.35
1.60
7.4
6.1
2.80
2.83
%
0.05
122
1043
11
50
2.25
1.59
1.6
3.1
53.99
59.64
%
0.38
11
50
146
1269
1.34
1.55
4.5
3.6
0.00
0.00
estimate
-0.00
29
259
234
2203
1.62
1.55
6.4
5.8
1.89
1.83
mu/l
0.33
221
2072
120
1015
1.34
1.52
3.8
3.3
6.26
6.18
ph
0.41
76
564
6
21
2.90
1.51
1.0
1.2
—
—
—
0
0
22
134
1.70
1.44
2.5
2.9
—
—
—
0
0
48
352
1.45
1.43
2.3
2.2
135.47
91.39
ug/g
0.56
38
279
38
267
1.50
1.40
6.6
7.1
103.42
104.19
mmol/l
0.38
38
267
253
2452
2.18
1.36
23.9
17.5
71.93
70.74
umol/l
0.23
253
2430
32
218
1.53
1.36
1.2
1.2
176.13
165.55
u/ml
0.04
11
94
19
113
1.74
1.36
6.4
3.3
23.69
24.79
mmol/l
1.27
19
113
0
37
0.00
1.35
0.0
1.3
—
—
—
0
0
112
952
1.31
1.33
4.4
3.5
0.00
0.01
estimate
0.80
24
217
75
603
1.34
1.31
3.2
5.1
—
—
—
0
0
125
1081
1.30
1.30
2.1
1.9
1.37
1.39
mmol/l
0.07
104
932
11
55
2.04
1.29
1.5
1.3
—
—
—
0
0
11
55
2.04
1.29
1.9
1.9
—
—
—
0
0
5
18
2.81
1.29
1.2
2.3
11.58
11.22
%
—
5
18
8
35
2.33
1.28
1.8
2.2
—
—
—
0
0
13
70
1.90
1.26
1.1
1.8
—
—
—
0
0
5
19
2.66
1.22
1.0
4.2
—
—
—
0
0
12
64
1.92
1.20
1.3
1.2
3.88
3.68
mmol/l
0.40
12
58
8
38
2.14
1.19
1.8
1.3
—
—
—
0
0
13
74
1.80
1.09
1.2
1.1
—
—
—
0
0
39
291
1.40
1.08
1.3
1.3
—
—
—
0
0
10
52
1.96
1.07
1.7
1.6
—
—
—
0
0
27
188
1.49
1.06
1.3
1.4
—
—
—
0
0
42
319
1.38
1.05
3.0
2.2
—
—
—
0
0
7
34
2.09
1.03
1.9
1.3
—
—
—
0
0
78
651
1.28
1.03
1.9
1.6
19.83
22.29
nmol/l
0.80
67
558
13
76
1.75
1.01
1.3
1.9
1.97
4.68
iu/l
—
5
32
89
759
1.26
0.98
2.7
3.1
7.55
7.33
mmol/l
0.18
74
635
12
70
1.75
0.94
1.1
1.1
—
—
—
0
0
233
2233
1.42
0.93
5.0
4.8
5.71
5.81
mmol/l
0.74
217
2088
6
30
2.02
0.87
1.0
1.4
—
—
—
0
0
26
189
1.42
0.85
4.3
3.6
—
—
—
0
0
247
2400
1.58
0.83
17.1
12.2
—
—
—
0
0
82
706
1.24
0.82
3.8
3.0
0.00
0.00
estimate
0.50
24
205
6
32
1.90
0.82
1.3
1.3
—
—
—
0
0
40
315
1.32
0.81
1.5
1.4
—
—
—
0
0
10
58
1.75
0.81
3.6
1.8
104.15
144.10
ug/l
—
10
52
14
91
1.57
0.77
1.6
2.0
17.86
3895.58
u/l
—
5
31
20
143
1.43
0.72
3.0
2.0
10.63
4.21
ug/l
0.80
20
127
23
170
1.39
0.70
10.3
9.1
—
—
—
0
0
21
153
1.41
0.69
1.1
1.1
—
—
—
0
0
7
43
1.64
0.67
1.1
1.0
—
—
—
0
0
7
44
1.61
0.65
2.9
1.8
6.07
6.41
pmol/l
—
7
44
111
1005
1.18
0.64
2.2
2.0
—
—
—
0
0
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
16
113
1.44
0.63
6.6
2.5
1.00
1.30
%
1.05
16
113
18
131
1.40
0.61
1.1
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
3.1
—
—
—
0
0
8
53
1.53
0.59
1.3
1.1
—
—
—
0
0
8
53
1.53
0.59
1.3
1.1
—
—
—
0
0
28
221
1.30
0.58
9.0
10.9
7.41
7.42
ph
0.13
16
132
36
295
1.26
0.57
1.5
1.5
—
—
—
0
0
11
74
1.51
0.54
1.3
1.7
—
—
—
0
0
121
1117
1.16
0.53
3.0
2.7
—
—
estimate
—
0
0
96
1049
0.87
0.50
3.1
3.0
—
—
—
0
0
7
46
1.54
0.48
1.1
1.1
—
—
—
0
0
15
111
1.37
0.48
2.2
2.3
—
—
—
0
0
12
85
1.43
0.47
3.8
2.2
1.44
1.50
g/l
—
5
77
15
112
1.36
0.45
4.1
2.5
0.57
0.59
%
0.12
15
112
77
696
1.15
0.44
5.0
3.8
0.00
0.00
estimate
0.50
29
246
11
78
1.43
0.44
1.1
1.1
—
—
—
0
0
25
303
0.81
0.42
1.3
1.4
—
—
—
0
0
83
757
1.14
0.42
2.7
2.2
—
—
—
0
0
17
132
1.31
0.41
6.9
7.3
25.02
24.95
mmol/l
0.03
17
132
37
317
1.19
0.40
2.0
1.5
—
—
—
0
0
5
34
1.48
0.40
1.4
1.3
—
—
—
0
0
47
413
1.17
0.39
1.6
1.6
—
—
—
0
0
0
19
0.00
0.39
0.0
2.6
—
3.99
—
0
19
0
19
0.00
0.39
0.0
2.6
—
1.19
—
0
19
0
19
0.00
0.39
0.0
2.6
—
105.53
—
0
19
11
80
1.39
0.39
8.7
6.2
—
—
—
0
0
24
198
1.23
0.38
6.4
3.5
7.37
7.39
ph
1.11
12
101
54
482
1.15
0.37
1.9
1.9
—
—
—
0
0
23
190
1.23
0.36
6.7
3.3
1.74
2.12
mmol/l
0.28
23
166
25
209
1.22
0.35
3.3
4.7
0.20
0.94
%
—
5
66
37
324
1.17
0.33
1.4
1.2
—
—
—
0
0
31
268
1.18
0.32
1.6
1.5
—
—
—
0
0
7
54
1.30
0.30
1.7
1.8
37.14
37.35
nmol/l
—
7
54
75
694
1.11
0.30
2.8
3.3
30.06
41.11
mg/l
0.24
50
400
7
55
1.28
0.30
1.7
2.5
7.42
7.42
ph
—
7
55
10
78
1.29
0.24
2.2
3.1
—
—
—
0
0
75
703
1.09
0.24
3.5
4.0
6.30
7.93
mg/mmol
0.13
42
387
219
2227
0.89
0.22
4.3
4.2
1.30
1.28
mmol/l
0.19
203
2077
5
40
1.25
0.22
2.8
3.1
3.57
4.80
e9/l
—
5
40
31
277
1.14
0.22
1.8
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
2.4
—
701.60
—
0
5
0
10
0.00
0.21
0.0
2.2
—
43.80
—
0
5
0
10
0.00
0.21
0.0
2.4
—
540.00
—
0
5
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
188.99
—
0
13
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
38.56
—
0
14
21
185
1.15
0.18
2.8
2.6
0.70
0.75
ug/l
0.25
12
103
7
58
1.21
0.18
2.1
3.4
23.99
24.79
mmol/l
—
7
58
240
2374
1.14
0.18
5.9
5.6
2.83
2.83
mmol/l
0.02
225
2230
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
19
167
1.15
0.17
1.4
1.9
—
—
—
0
0
7
63
1.11
0.17
2.3
2.5
26.37
24.60
mmol/l
—
7
63
5
68
0.73
0.17
3.8
2.3
1.55
1.32
mg/l
—
5
60
6
79
0.75
0.15
1.5
1.3
—
—
—
0
0
9
81
1.12
0.15
12.1
11.1
1.03
0.89
%
—
9
76
11
93
1.19
0.14
1.6
1.4
243.45
251.64
miu/ml
—
5
50
8
100
0.79
0.14
4.0
2.6
1.01
1.02
ratio
—
8
94
23
210
1.10
0.12
3.4
2.5
0.20
0.23
g/l
0.77
23
199
237
2349
1.10
0.12
5.1
5.0
4.78
4.83
mmol/l
0.34
224
2214
12
105
1.15
0.11
3.0
1.7
—
—
—
0
0
23
249
0.92
0.10
2.0
1.8
3.21
3.46
mmol/l
0.42
12
187
5
45
1.11
0.10
1.4
2.0
—
—
—
0
0
13
116
1.13
0.09
8.5
8.7
—
—
—
0
0
13
144
0.90
0.08
15.4
7.4
9.78
8.27
mmol/l
0.45
13
138
254
2529
1.19
0.07
28.7
21.4
30.16
30.27
pg
0.52
254
2511
254
2529
1.19
0.07
29.3
21.9
40.60
40.54
%
0.10
254
2508
6
70
0.85
0.07
1.3
1.3
—
—
—
0
0
254
2530
1.17
0.07
29.0
21.7
135.12
135.10
g/l
0.01
254
2510
254
2528
1.21
0.07
28.7
21.5
90.47
90.96
fl
1.09
254
2510
12
108
1.12
0.07
1.2
1.2
—
—
—
0
0
8
94
0.85
0.07
7.3
4.3
37.00
36.96
°c
—
8
94
20
213
0.93
0.06
1.4
1.3
—
—
—
0
0
22
231
0.95
0.04
2.8
4.1
3.34
8.87
ug/l
1.48
14
188
70
711
0.98
0.03
1.6
1.5
—
—
—
0
0
234
2337
1.01
0.00
5.0
4.9
1.48
1.53
mmol/l
1.02
219
2193
26
263
0.99
0.00
1.5
1.8
—
—
—
0
0
10
103
0.97
0.00
1.0
1.1
1.46
1.57
g/l
—
10
103
11
106
1.04
0.00
1.6
1.1
0.88
0.89
g/l
0.04
11
106
17
174
0.98
0.00
2.8
3.1
70.71
76.20
e9/l
0.29
11
123
0
5
0.00
0.00
0.0
1.6
—
59.20
—
0
5
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
14.91
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
1.57
—
0
6
0
9
0.00
-0.00
0.0
8.6
—
16.41
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
0.06
—
0
6
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
5
52
0.96
-0.00
1.4
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.20
—
0
6
6
61
0.98
-0.00
2.7
2.8
62.18
59.56
%
—
6
61

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: MIGRAINE_UNSPE – Migraine, unspecified, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).